[Successful treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocytes infusion: three cases report and literatures review].

[1]  E. Lanino,et al.  Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. , 2017, The Lancet. Oncology.

[2]  D. Ginat,et al.  Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma , 2015, Journal of Neuro-Oncology.

[3]  R. Foà,et al.  Proven Epstein–Barr encephalitis with negative EBV‐DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia , 2014, Pediatric transplantation.

[4]  K. Koike,et al.  Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review , 2015, International Journal of Hematology.

[5]  H. Heslop,et al.  Epstein–Barr virus lymphoproliferative disease after hematopoietic stem cell transplant , 2014, Current opinion in hematology.

[6]  J. Wachowiak,et al.  Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder , 2013, Leukemia & lymphoma.

[7]  Y. Nojima,et al.  Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder , 2011, International journal of hematology.

[8]  A. Ibatici,et al.  Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  E. Thiel,et al.  Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents , 2011, Haematologica.

[10]  T. Okamura,et al.  Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection , 2011, Bone Marrow Transplantation.

[11]  T. Nakao,et al.  [Epstein-Barr virus-associated post-transplant lymphoproliferative disorder diagnosed by the episode of intestinal perforation following allogeneic hematopoietic stem cell transplantation]. , 2010, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[12]  L. Gordon,et al.  Post-Transplantation Lymphoproliferative Disorders: Diagnosis, Prognosis, and Current Approaches to Therapy , 2010, Current oncology reports.

[13]  G. Ledderose,et al.  Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. , 2010, Blood.

[14]  H. Einsele,et al.  Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia , 2009, Bone Marrow Transplantation.

[15]  P. Sundgren,et al.  The Neuroanatomic Localization of Epstein-Barr Virus Encephalitis May be a Predictive Factor for its Clinical Outcome: A Case Report and Review of 100 Cases in 28 Reports , 2009, Journal of child neurology.

[16]  K. Kawa,et al.  Allogeneic hematopoietic stem cell transplantation for Epstein–Barr virus‐associated T/natural killer‐cell lymphoproliferative disease in Japan , 2008, American journal of hematology.

[17]  I. Ahmad,et al.  Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report , 2006, European journal of haematology.

[18]  N. Schmitz,et al.  Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe , 2002, Bone Marrow Transplantation.

[19]  T. Terasawa,et al.  Failure to Detect Epstein-Barr Virus (EBV) DNA in Plasma by Real-Time PCR in a Case of EBV-Associated Posttransplantation Lymphoproliferative Disorder Confined to the Central Nervous System , 2002, International journal of hematology.

[20]  B. van der Holt,et al.  Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. , 2001, Blood.